RSS

BBL BHP Billiton PLC

Last Post: 03/23/19
Followers: 0
Posts Today: 0
Views Today: 2

BBL Stock Quote & Tools

BBL Stock Message Board Discussion

Top 10 Most Recent News Articles

Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 5

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading
Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Updated Category News Views 3

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Continue Reading
Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 13

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
Community Heritage Financial Declares Q3 2026 Dividend

Updated Category News Views 4

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Continue Reading
Home Bancorp CEO Transition: Guidry Takes the Helm

Updated Category News Views 5

Leadership Change at Home Bancorp In the world of banking, transition phases can either be a smooth baton pass or a dramatic handoff. With Home Bancorp, Inc. (NASDAQ: HBCP) announcing John W. Bordelon's upcoming retirement as CEO, effective January 8, 2027, we’re looking at a calculated and down-the-line transfer of power to Darren E. Guidry. More often than not, the...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 5

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
F.N.B. Q3 2026 Earnings: Solid Growth Continues

Updated Category News Views 4

F.N.B. Stays the Course with Strong Q3 2026 Ever heard the phrase “slow and steady wins the race?” That seems to be the mantra over at F.N.B. Corporation (NYSE: FNB) as they roll out their Q3 2026 earnings. Now, they aren't breaking any land speed records, but what they are doing is consistently stepping up their game, quarter by quarter, like clockwork. Drilling Down...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 5

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 9

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 9

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading

Top 5 Most Recently Viewed Articles

Profiting from SPDR Gold MiniShares Trust: 5-Year Review

Updated Category News Views 118

Understanding the SPDR Gold MiniShares Trust Performance SPDR Gold MiniShares Trust (NYSE: GLDM) has shown impressive returns over the past five years, outperforming the market by an average of 5.19% annually. With a market cap currently estimated at $25.61 billion, this fund has attracted the attention of investors looking to diversify their portfolios with gold. Initial...

Continue Reading
Ortel Announces Major Advancements in Laser Technology

Updated Category News Views 370

Ortel's Strategic Move for Laser Fabrication Transfer Ortel, a prominent enterprise in photonics, has made headlines with the recent announcement regarding its wafer fabrication transfer for the C-Band High-Power Continuous Wave Laser Module platform. This significant shift to the Canadian Photonics Fabrication Centre (CPFC) marks a pivotal moment for the company,...

Continue Reading
GENFIT's GNS561 Aims to Revolutionize Cancer Treatment Options

Updated Category News Views 184

Unveiling the Promise of GNS561 in Combination Therapy Recent findings from GENFIT have unveiled striking early results from an ongoing clinical study involving GNS561, an innovative investigational drug. The combination of GNS561 with a MEK inhibitor (MEKi) is showing encouraging potential, especially for patients suffering from KRAS mutated cholangiocarcinoma (CCA), a...

Continue Reading
Notable Shareholding Changes for Spar Nord Fonden Announced

Updated Category News Views 81

Spar Nord Fonden's Major Shareholder Update Announcement Overview In a noteworthy step within the financial sector, Spar Nord Fonden has informed Spar Nord Bank A/S of an increase in its ownership. They've amassed a total of 23,853,707 shares, which represents 20.27% of Spar Nord Bank A/S's total share capital. This significant move not only showcases Spar Nord Fonden's...

Continue Reading
Equiduct Announces Martin Andersson as New Nordic Head

Updated Category News Views 188

Martin Andersson Joins Equiduct as Head of Nordics Equiduct is excited to introduce Martin Andersson as the new Head of Nordics. With more than 25 years in financial markets, Martin brings expertise that promises to enhance Equiduct's vision and strategy within the Nordic region. A Wealth of Experience in Financial Markets Before joining Equiduct, Martin developed a...

Continue Reading